KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Acquisitions & Divestments (2009 - 2021)

Boston Scientific recorded quarterly Change in Acquisitions & Divestments of -$23.0 million in Q2 2021, down 160.53% quarter-over-quarter from $38.0 million in Q1 2021.

Boston Scientific's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at -$23.0 million for Q2 2021.

  • In Q2 2021, Change in Acquisitions & Divestments changed N/A year-over-year to -$23.0 million; the TTM figure through Sep 2022 stood at $15.0 million (changed 0.0% YoY), while the FY2015 annual figure was $61.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at -$23.0 million for Q2 2021 at Boston Scientific, down from $38.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $38.0 million in Q1 2021 to a low of -$23.0 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 -23.00 Mn
Jun 30, 2021 -23.00 Mn
Mar 31, 2021 38.00 Mn
Mar 31, 2021 38.00 Mn
Sep 30, 2011 1.00 Mn
Sep 30, 2011 1.00 Mn
Dec 31, 2010 3.00 Mn
Dec 31, 2010 3.00 Mn
Dec 31, 2009 37.00 Mn
Dec 31, 2009 37.00 Mn
Sep 30, 2009 4.00 Mn
Sep 30, 2009 4.00 Mn
Mar 31, 2009 50.00 Mn
Mar 31, 2009 50.00 Mn